report-bg

Viral Warts Treatment Market

Segmentation by Treatment (Physical Destruction, Chemical Destruction, Immunomodulation, and Others); by Mode of Administration (Injectable, Oral, and Others); by Drug Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies); and by End User (Hospitals, Homecare, Specialty Clinics, and Others) – Global Demand Analysis & Opportunity Outlook 2030

Buy Now
Report ID: 3632 | Published On: Feb 07, 2023
Request Free Sample Copy

Global Viral Warts Treatment Market Regional Synopsis

On the basis of geographical analysis, the global viral warts treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. The market in the North America is estimated to gather the largest share over the forecast period on the back of the rising awareness regarding different treatment options, well-established healthcare infrastructure and high healthcare spending in the region. As per the data provided by the Centers for Disease Control and Prevention, the total national health expenditure in the United States accounted for a value of USD 3.6 trillion in 2018, or USD 11,172 per capita. The total value of the same as share of GDP was 17.7 percent that year. In addition, increase in drug approvals is also expected to boost the region’s market growth in the coming years. Moreover, the market in Europe is also predicted to acquire a notable share during the forecast period, which can be credited to the growing research and development activities in the healthcare sector, and presence of prominent market players in the region.

Viral Warts Treatment Market Share Image

Get more information on this reportDownload Sample PDF

The global viral warts treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook


Viral Warts Treatment Market Graph
Get more information on this report: Request Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth
cscs

Healthcare Expenditure per Capita Graph

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Market Segmentation

Our in-depth analysis of the global viral warts treatment market includes the following segments:

By Treatment

  • Physical Destruction
  • Chemical Destruction
  • Immunomodulation
  • Others

By Mode of Administration

  • Injectable
  • Oral
  • Others

By Drug Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Growth Drivers

  • Growing Prevalence of Skin Disorders Across the World
  • Rising Clinical Trials Conducted by Various Pharmaceutical Companies

Challenges

  • Lack of Awareness about Diagnosis of Viral Warts


Healthcare Expenditure per Capita Graph
Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

    • Pfizer, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Teva Pharmaceutical Industries Ltd
    • Phio Pharmaceuticals Corp.
    • GlaxoSmithKline Plc
    • Bausch Health Companies, Inc.
    • Mylan N.V.
    • Taro Pharmaceutical Industries Ltd
    • Verrica Pharmaceuticals Inc.
    • Novan Inc
    • Merck & Co., Inc.

In The News

  • September 2021- Mylan received approval from the Subject Expert Committee of the Central Drugs Standard Control Organization, or CDSCO, for importing and marketing Cutaneous Cryogenic Spray of Endwarts Freeze and Endwarts Freeze XL.

  • December 2020- Verrica Pharmaceuticals announced the resubmission of New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum) to the U.S. Food and Drug Administration (FDA).


Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Key Questions Answered in the Report

1) What are the major factors driving the growth of the viral warts treatment market?

Ans: The major factors driving market growth are growing prevalence of skin disorders across the world and rising clinical trials conducted by various pharmaceutical companies.

2) What would be the CAGR of viral warts treatment market over the forecast period?

Ans: The market is anticipated to attain a CAGR of ~3% over the forecast period, i.e., 2022 – 2030.

3) What are the challenges affecting the viral warts treatment market growth?

Ans: Lack of awareness about diagnosis of viral warts is estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of viral warts treatment market in future?

Ans: North America will provide more business opportunities for market growth owing to the rising awareness regarding different treatment options, and well-established healthcare infrastructure.

5) Who are the major players dominating the viral warts treatment market?

Ans: The major players in the market are Pfizer, Inc., Teva Pharmaceutical Industries Ltd, Phio Pharmaceuticals Corp., GlaxoSmithKline Plc, Bausch Health Companies, Inc., and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the viral warts treatment market?

Ans: The market is segmented by treatment, drug distribution channel, mode of administration, end user, and by region.

8) Which segment captures the largest market size in the treatment segment in the viral warts treatment market?

Ans: The physical destruction segment is anticipated to hold largest market size in value and is estimated to grow at a notable CAGR over the forecast period and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample